These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 38659080)
21. N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability. Ji Y; Zhao Q; Feng W; Peng Y; Hu B; Chen Q Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428672 [TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer. Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613 [TBL] [Abstract][Full Text] [Related]
23. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma. Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946 [TBL] [Abstract][Full Text] [Related]
24. Zhao A; Wang Y; Wang Z; Shao Q; Gong QI; Zhu H; Shen S; Liu HU; Chen X Oncol Res; 2024; 32(5):983-998. PubMed ID: 38686044 [TBL] [Abstract][Full Text] [Related]
25. The N Lin C; Ma M; Zhang Y; Li L; Long F; Xie C; Xiao H; Liu T; Tian B; Yang K; Guo Y; Chen M; Chou J; Gong N; Li X; Hu G Mol Cancer; 2022 Mar; 21(1):80. PubMed ID: 35305647 [TBL] [Abstract][Full Text] [Related]
26. Identification and Characterization of N6-Methyladenosine CircRNAs and Methyltransferases in the Lens Epithelium Cells From Age-Related Cataract. Li P; Yu H; Zhang G; Kang L; Qin B; Cao Y; Luo J; Chen X; Wang Y; Qin M; Wu J; Huang Y; Zou X; Guan H; Wang Y Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):13. PubMed ID: 32761139 [TBL] [Abstract][Full Text] [Related]
27. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent. Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103 [TBL] [Abstract][Full Text] [Related]
28. Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma. Wang H; Tao Y; Han J; Shen J; Mu H; Wang Z; Wang J; Jin X; Zhang Q; Yang Y; Lin J; Sun M; Ma X; Ren L; LeBlanc AK; Xu J; Hua Y; Sun W Cell Oncol (Dordr); 2024 Oct; 47(5):1845-1861. PubMed ID: 39115605 [TBL] [Abstract][Full Text] [Related]
29. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207 [TBL] [Abstract][Full Text] [Related]
30. Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway. Xu Z; Chen S; Liu R; Chen H; Xu B; Xu W; Chen M Mol Cancer; 2022 Jul; 21(1):146. PubMed ID: 35840930 [TBL] [Abstract][Full Text] [Related]
31. EGR2-mediated regulation of m Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314 [TBL] [Abstract][Full Text] [Related]
32. N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1. Li J; Xu X; Xu K; Zhou X; Wu K; Yao Y; Liu Z; Chen C; Wang L; Sun Z; Jiao D; Han X J Exp Clin Cancer Res; 2024 Apr; 43(1):119. PubMed ID: 38641828 [TBL] [Abstract][Full Text] [Related]
33. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Du A; Li S; Zhou Y; Disoma C; Liao Y; Zhang Y; Chen Z; Yang Q; Liu P; Liu S; Dong Z; Razzaq A; Tao S; Chen X; Liu Y; Xu L; Zhang Q; Li S; Peng J; Xia Z Mol Cancer; 2022 May; 21(1):109. PubMed ID: 35524319 [TBL] [Abstract][Full Text] [Related]
34. N Shu G; Zhao Z; Zhao T; Deng C; Zhu J; Han Y; Chen M; Jing J; Bai G; Li D; Li F; He J; Fu W; Liu G J Exp Clin Cancer Res; 2024 Jul; 43(1):191. PubMed ID: 38987793 [TBL] [Abstract][Full Text] [Related]
35. Myosin light chain 9 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells by binding to Yes-associated protein 1 and regulating Hippo signaling. Feng M; Dong N; Zhou X; Ma L; Xiang R Bioengineered; 2022 Jan; 13(1):96-106. PubMed ID: 34974798 [TBL] [Abstract][Full Text] [Related]
36. METTL14-mediated m Fan HN; Chen ZY; Chen XY; Chen M; Yi YC; Zhu JS; Zhang J Mol Cancer; 2022 Feb; 21(1):51. PubMed ID: 35164771 [TBL] [Abstract][Full Text] [Related]
37. N6-methyladenosine-modified circCDK14 promotes ossification of the ligamentum flavum via epigenetic modulation by targeting AFF4. Zhao Y; Chen L; Xiang Q; Lin J; Jiang S; Li W Cell Mol Life Sci; 2024 Oct; 81(1):436. PubMed ID: 39414635 [TBL] [Abstract][Full Text] [Related]
38. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling. Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892 [TBL] [Abstract][Full Text] [Related]
39. Circ_0091537 promotes gefitinib chemoresistance in non-small cell lung cancer by mediating the miR-520h/YAP1 network. Qu R; Ma J Anticancer Drugs; 2023 Nov; 34(10):1151-1161. PubMed ID: 36727737 [TBL] [Abstract][Full Text] [Related]